GlassScriptPhysician profile
Richard L Cristea
NPI 1992858641
$30,007.14
in general payments reported to CMS, 2019-2025
82 companies · $5,571 in 2025
The $5,571 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,964 · 2020: $2,914 · 2021: $4,046 · 2022: $4,929 · 2023: $4,934 · 2024: $5,649 · 2025: $5,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Consulting Fee: $300 · Education: $49.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,804.52 |
| Consulting Fee | $300.00 |
| Education | $49.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $3,326.44 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Novartis Pharmaceuticals Corporation | $1,971.69 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,801.66 | 2019-2025 | Austedo, Austedo Xr, Austedo Xr |
| Abbvie INC. | $1,595.64 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Jazz Pharmaceuticals INC. | $1,505.88 | 2019-2025 | Xywav |
| Emd Serono, INC. | $1,193.99 | 2019-2025 | Mavenclad, Mavenclad |
| Neurocrine Biosciences, INC. | $1,177.57 | 2019-2025 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $925.81 | 2019-2024 | Ultomiris, Soliris |
| Genzyme Corporation | $756.51 | 2019-2025 | |
| Horizon Therapeutics Plc | $741.42 | 2020-2023 | Uplizna |
| Amgen INC. | $721.61 | 2019-2025 | Uplizna |
| Lilly USA, LLC | $670.83 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Lundbeck LLC | $645.03 | 2020-2025 | Vyepti, Rexulti |
| Argenx US, INC. | $641.83 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Avadel Cns Pharmaceuticals, LLC | $632.46 | 2024-2025 | Lumryz |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $614.27 | 2020-2022 | |
| Celgene Corporation | $575.12 | 2021-2025 | Zeposia |
| Sk Life Science, INC. | $535.23 | 2021-2025 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $522.97 | 2020-2025 | Rexulti, Nuedexta |
| Acorda Therapeutics, INC | $506.60 | 2019-2024 | Inbrija, Ampyra |
| Livanova USA, INC. | $500.12 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Tg Therapeutics, INC. | $472.49 | 2023-2025 | |
| Allergan, INC. | $462.89 | 2019-2022 | |
| Axsome Therapeutics, INC. | $446.62 | 2022-2025 | Sunosi, Symbravo, Auvelity |
| Eisai INC. | $439.97 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $432.53 | 2020-2025 | Fycompa |
| Takeda Pharmaceuticals U.S.A., INC. | $417.79 | 2019-2024 | Trintellix |
| Ucb, INC. | $396.93 | 2020-2025 | Briviact, Nayzilam |
| Pfizer INC. | $364.20 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $309.45 | 2020-2025 | Nuplazid, Daybue |
| Merz Pharmaceuticals, LLC | $302.25 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Mdd US Operations, LLC | $285.00 | 2019-2025 | Apokyn, Apokyn |
| Supernus Pharmaceuticals, INC. | $271.45 | 2019-2024 | Qelbree |
| Genentech USA, INC. | $257.67 | 2020-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Harmony Biosciences LLC | $242.23 | 2020-2025 | Wakix |
| Neurelis, INC. | $235.92 | 2022-2025 | Valtoco |
| Corium, LLC | $216.66 | 2022-2025 | Azstarys, Adlarity |
| Csl Behring | $198.60 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $197.27 | 2022-2025 | Purified Cortrophin Gel |
| Sunovion Pharmaceuticals INC. | $184.30 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $160.56 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $151.87 | 2024-2025 | Ponvory |
| Kyowa Kirin, INC. | $146.05 | 2020-2022 | |
| Banner Life Sciences, LLC | $120.18 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $119.08 | 2022 | |
| Inspire Medical Systems, INC. | $118.10 | 2022 | |
| Itamar Medical INC | $109.82 | 2022-2024 | Watchpatone |
| E.R. Squibb & Sons, L.L.C. | $101.96 | 2020-2024 | Zeposia |
| Scilex Pharmaceuticals INC. | $100.28 | 2020-2025 | |
| Octapharma USA, INC. | $87.44 | 2024-2025 | Panzyga |
| Mallinckrodt Hospital Products INC. | $76.61 | 2021-2023 | Acthar |
| Akcea Therapeutics, INC. | $76.56 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $69.99 | 2020-2023 | Jornay Pm |
| Alfasigma USA, INC. | $65.41 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $54.58 | 2020-2025 | Crexont |
| Cycle Pharmaceuticals INC | $51.92 | 2025 | Bafiertam, Tascenso Odt |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $50.81 | 2025 | Rexulti |
| Abbott Laboratories | $49.59 | 2023-2025 | Eterna, Infinity |
| Tanabe Pharma America, INC. | $49.46 | 2021-2024 | |
| Avion Pharmaceuticals | $43.14 | 2021-2022 | |
| Bausch Health US, LLC | $42.85 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $41.02 | 2021 | |
| Vertical Pharmaceuticals, LLC | $36.57 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $36.34 | 2019 | |
| Impel Pharmaceuticals INC. | $27.53 | 2023 | Trudhesa |
| Mallinckrodt Enterprises LLC | $25.83 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $25.33 | 2019-2020 | |
| Aucta Pharmaceuticals, INC. | $24.11 | 2025 | Motpoly Xr |
| Janssen Biotech, INC. | $23.57 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $23.04 | 2021 | |
| Azurity Pharmaceuticals, INC. | $22.77 | 2024 | Horizant |
| Avanir Pharmaceuticals, INC. | $22.65 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.70 | 2025 | Caplyta |
| Springworks Therapeutics, INC. | $21.48 | 2025 | Gomekli |
| Tersera Therapeutics LLC | $17.72 | 2022 | |
| Impel Pharmaceuticals LLC | $16.96 | 2024 | Trudhesa |
| Tris Pharma INC | $14.66 | 2024 | Dyanavel Xr |
| Cala Health, INC. | $14.53 | 2024 | Cala Kiq, Cala Trio |
| Assertio Therapeutics, INC. | $13.91 | 2019 | |
| Merz North America, INC. | $12.32 | 2020 | |
| Boston Scientific Corporation | $12.28 | 2021 | |
| Ge Healthcare | $9.66 | 2020 |
Drugs and devices associated with these payments
Tysabri $1,343Vumerity $1,260Kesimpta $829Uplizna $823Ingrezza $688Lumryz $632Epidiolex $569Qulipta $562Xywav $553Ultomiris $479Briumvi $472Rexulti $462Vyvgart $461Botox $459Zeposia $358Fycompa $354Amyvid $346Sunosi $341Ubrelvy $322Vns Therapy Sentiva Model 1000 Generator $321Nurtec Odt $305Kisunla $302Austedo Xr $298Zavzpret $291Nuplazid $219Mavenclad $217Inbrija $210Ampyra $186Vyvgart Hytrulo $181Vyepti $177Briviact $174Purified Cortrophin Gel $173Xeomin $173Ongentys $171Austedo $171Mayzent $157Leqembi $153Ponvory $152Xcopri $147Bafiertam $140Nayzilam $137Emgality $134Azstarys $127Panzyga $121Ocrevus $116Wakix $109Ocrevus Zunovo $91.21Avonex $82.69Reyvow $73.05Apokyn $72.27Symbravo $68.60Valtoco $66.92Qelbree $63.66Watchpatone $50.25Ztlido $46.57Trudhesa $44.49Vraylar $41.74Duopa $38.88Acthar $38.41Daybue $35.82Soliris $35.63Tascenso Odt $34.33Eterna $34.03Jornay Pm $30.77Nuedexta $30.13Octagam Immune Globulin (Human) $29.00Paxlovid $26.30Motpoly Xr $24.11Comirnaty $23.96Aubagio $23.18Horizant $22.77Adlarity $22.33Caplyta $21.70Gomekli $21.48Skyclarys $21.29Auvelity $15.90Elyxyb - Celecoxib $15.73Infinity $15.56Dyanavel Xr $14.66Cala Trio $14.53Cala Kiq $14.53Plegridy $14.36Enspryng $14.08Trintellix $13.87Crexont $13.48Vyalev $12.77
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Cristea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.